A Multicenter Clinical Study of Apatinib Mesylate Combined With Doctor's Choice for Advanced Breast Cancer
Clinical trial NCT06339281 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06339281
- Sponsor
- Li Huiping
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-01
- Primary completion
- 2026-06-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.